DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on September 20, 2005; DOI: 10.1124/dmd.105.005389


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.005389v1
33/12/1852    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallifax, D.
Right arrow Articles by Houston, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallifax, D.
Right arrow Articles by Houston, J. B.


Received for publication May 3, 2005.
Revised September 15, 2005.
Accepted for publication September 16, 2005.

PREDICTION OF METABOLIC CLEARANCE USING CRYOPRESERVED HUMAN HEPATOCYTES: KINETIC CHARACTERISTICS FOR FIVE BENZODIAZEPINES

David Hallifax 1, Helen C Rawden 1, Nancy Hakooz 1, J. Brian Houston 1*

1 University of Manchester

* Address correspondence to: E-mail: brian.houston{at}man.ac.uk

Abstract

Abstract Predictions of intrinsic clearance (CLint) from human liver microsomes often underestimate in vivo observations. In this study, a series of five benzodiazepines were used as prototypic CYP3A4 substrates in order to investigate the prediction of clearance from the less studied alternative in vitro system, cryopreserved human hepatocytes. Formation of the two major metabolites from midazolam, triazolam, diazepam, flunitrazepam and alprazolam was measured in cryopreserved human hepatocytes from five donors; the kinetics were characterised and CLint values determined and scaled to predict CLint in vivo. At least one of the two major pathways of metabolic clearance of each benzodiazepine was characterised by autoactivation in hepatocytes; the extent to which this occurred varied depending on substrate and liver (up to 8-fold). Heteroactivation by testosterone of these pathways was also observed (up to 6-fold). The maximum autoactivated clearance was used to predict in vivo CLint (1.6 - 138ml/min/kg) which closely agreed with values previously obtained using human liver microsomes. Comparison with in vivo CLint indicates that cryopreserved human hepatocytes systematically under-predict CLint. When three previous studies (documenting CLint for substrates of various enzymes in cryopreserved human hepatocytes using drug depletion-time profiles) were considered as well, the combined data show a consistent underprediction of 5.6-fold. Collectively it is demonstrated that the predicted hepatic intrinsic clearances from cryopreserved hepatocytes show an excellent rank order with in vivo findings but are systematically under-predicting the in vivo value.


Key words: drug clearance, enzyme kinetics, hepatic elimination, hepatocytes, human CYP enzymes, in vitro-in vivo prediction, in vitro-in vivo scaling


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. B. Dennison, M. A. Mohutsky, R. J. Barbuch, S. A. Wrighton, and S. D. Hall
Apparent High CYP3A5 Expression Is Required for Significant Metabolism of Vincristine by Human Cryopreserved Hepatocytes
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 248 - 257.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. J. Parker and J. B. Houston
Rate-Limiting Steps in Hepatic Drug Clearance: Comparison of Hepatocellular Uptake and Metabolism with Microsomal Metabolism of Saquinavir, Nelfinavir, and Ritonavir
Drug Metab. Dispos., July 1, 2008; 36(7): 1375 - 1384.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. S. Brown, A. Chadwick, and J. B. Houston
Use of Isolated Hepatocyte Preparations for Cytochrome P450 Inhibition Studies: Comparison with Microsomes for Ki Determination
Drug Metab. Dispos., November 1, 2007; 35(11): 2119 - 2126.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Hallifax and J. B. Houston
Saturable Uptake of Lipophilic Amine Drugs into Isolated Hepatocytes: Mechanisms and Consequences for Quantitative Clearance Prediction
Drug Metab. Dispos., August 1, 2007; 35(8): 1325 - 1332.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H. S. Brown, M. Griffin, and J. B. Houston
Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance
Drug Metab. Dispos., February 1, 2007; 35(2): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Hallifax and J. B. Houston
Uptake and Intracellular Binding of Lipophilic Amine Drugs by Isolated Rat Hepatocytes and Implications for Prediction of in Vivo Metabolic Clearance
Drug Metab. Dispos., November 1, 2006; 34(11): 1829 - 1836.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Lu, P. Li, R. Gallegos, V. Uttamsingh, C. Q. Xia, G. T. Miwa, S. K. Balani, and L.-S. Gan
Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in Hepatocytes
Drug Metab. Dispos., September 1, 2006; 34(9): 1600 - 1605.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.